© 2021 MJH Life Sciences™ and Pharmacy Times. All rights reserved.
July/August 2013
Growth Hormone Therapy: A Specialty Pharmacy Overview
August 13, 2013
Article
Clinical Insights
Growth hormone deficiency in children and adults is a disease state that utilizes growth hormone therapy. Here is what specialty pharmacists can do for these patients and what they should know about these conditions.
Many Antibody-Positive Patients Are Never HCV RNA Tested
August 13, 2013
Article
Disease State Management
RSV Infections in Infancy Linked to Wheezing in Childhood
August 13, 2013
Article
Disease State Management
Triple Therapy May Cause More Adverse Reactions in HCV Patients
August 13, 2013
Article
Disease State Management
Synergies in Specialty: The 3 P's of Specialty Pharmacy--Pharmacy, Payer, and Product
August 09, 2013
Article
Features
In the development of a specialty pharmacy strategy, there are many key stakeholders, but none more important than the pharmacy, payer, and product. Each has its own mission and goals; however, at some point they must all come together.
Adding a Specialty Pharmacy to Your Retail Brand
August 09, 2013
Article
Viewpoints: The Last Word
With the growth of specialty pharmacies in retail, there are new tracking and reporting challenges to consider and conquer.
How Smartphones Will Transform Your Patient Relationships
August 09, 2013
Article
Features
Interactive, real-time, 24/7 patient connections will change the way patient care is delivered and offer new ways of doing business for specialty pharmacy.
Who Really Knows Best?
August 09, 2013
Article
Specialty Speaks
Why are limited distribution networks found only in the United States? Does pharma know best?
The Challenge of Specialty Pharmacy: Mitigating Costs While Providing Quality Care
August 08, 2013
Article
Features
The cost of complex therapies is soaring, and the challenge is to deliver access to these medications in the most cost-effective and clinically appropriate site of service.
Cancer Patients Require Coordinated Care
August 08, 2013
Article
Features
Treatment advances have made many cancers a chronic disease rather than a terminal disease. Here is how one dedicated team works to coordinate care and work with patients.
Near-Term Specialty Pipeline Highlights
August 08, 2013
Article
New Product Pipeline
A significant number of new specialty medications are on track to be approved in 2013, and some will provide increased competition in certain therapy classes.
New Roles for Oncology Pharmacists
August 07, 2013
Article
Oncology Trends
These pharmacists have specialized knowledge about pharmaceuticals and their use in treating cancer and its comorbidities, and they work collaboratively with the health care team to optimize outcomes.
The Challenges and Rewards of Launching an Orphan Drug
August 07, 2013
Article
Compliance Corner
With orphan drugs under the microscope, it's important to review the special circumstances and challenges of this group.
Part D Plans and PBMs Face New Reporting Requirements
August 07, 2013
Article
Washington Insights
A rule from CMS requires, in part, that Medicare Advantage organizations and Medicare Part D plan sponsors have the ability to obtain data.
Young Infants at Greatest Risk for RSV Hospitalization
August 05, 2013
Article
Disease State Management
Understanding the 3 P's of Specialty Pharmacy
August 05, 2013
Article
Editorial
Many factors come into play when establishing a distribution model, and the 3 P's-Pharmacy, Payer, and Product-are all key stakeholders and part of the story.
RSV Just as Deadly as Flu in Elderly Patients
August 01, 2013
Article
Disease State Management
A new study finds that RSV infections in elderly patients can lead to respiratory failure, prolonged hospitalizations, and morbidity rates similar to those caused by seasonal influenza.